AI assistant
Schrodinger, Inc. — Director's Dealing 2020
Feb 12, 2020
31925_dirs_2020-02-12_cc47ac05-7194-4def-ac88-895b86414e5f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Schrodinger, Inc. (SDGR)
CIK: 0001490978
Period of Report: 2020-02-10
Reporting Person: BILL & MELINDA GATES FOUNDATION TRUST (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-10 | Common stock | C | 6393429 | — | Acquired | 6393429 | Direct |
| 2020-02-10 | Common stock | P | 588235 | $17.00 | Acquired | 6981664 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-10 | Series B preferred stock | $ | C | 29468101 | Disposed | Common stock (3942041) | Direct | |
| 2020-02-10 | Series C preferred stock | $ | C | 47242235 | Disposed | Common stock (6319743) | Direct | |
| 2020-02-10 | Series D preferred stock | $ | C | 35946010 | Disposed | Common stock (4808612) | Direct | |
| 2020-02-10 | Series E preferred stock | $ | C | 33543539 | Disposed | Common stock (4487226) | Direct | |
| 2020-02-10 | Limited common stock | $ | C | 13164193 | Acquired | Common stock (13164193) | Direct |
Footnotes
F1: Upon closing of the Issuer's initial public offering ("IPO"), all of the Series E preferred stock held by Bill & Melinda Gates Foundation Trust (the "Trust") converted automatically into the Issuer's common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series E preferred stock.
F2: Represents shares acquired pursuant to an Issuer directed allocation in connection with the Issuer's IPO of common stock.
F3: Upon closing of the Issuer's IPO, the Trust voluntarily exchanged all of its Series B preferred stock and Series C preferred stock into the Issuer's limited common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series B preferred stock or Series C preferred stock.
F4: Upon closing of the Issuer's IPO, (i) 14,249,523 shares of Series D preferred stock converted automatically into the Issuer's common stock on a 7.47534-for-1 basis without payment of further consideration and (ii) 21,696,487 shares of Seried D preferred stock were voluntarily exchanged at the discretion of the Trust into the Issuer's limited common stock on a 7.47534-for-1 basis without further consideration. There was no expiration date for the Series D preferred stock.
F5: All shares of the Issuer's limited common stock have no expiration date and may be exchanged at the Trust's election into the Issuer's common stock on a 1-for-1 basis without payment of further consideration.